Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
FDA accepts Pfizer's filing for axitinib review for advanced renal cell carcinoma

FDA accepts Pfizer's filing for axitinib review for advanced renal cell carcinoma

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

Omeros identifies compounds that interact with orphan GPCRs associated with leukemia

Omeros identifies compounds that interact with orphan GPCRs associated with leukemia

Teva concludes Site Initiation Visit for Israeli clinical center in CEL-SCI's Multikine Phase III clinical trial

Teva concludes Site Initiation Visit for Israeli clinical center in CEL-SCI's Multikine Phase III clinical trial

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

Nontoxic gold nanoparticles could detect growth of early tumors in liver

Nontoxic gold nanoparticles could detect growth of early tumors in liver

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Theorem Clinical Research receives contract to conduct Nordion's TheraSphere Phase III trials

Theorem Clinical Research receives contract to conduct Nordion's TheraSphere Phase III trials

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

OncoSec Medical third quarter net loss increases to $491,000

OncoSec Medical third quarter net loss increases to $491,000

immatics initiates IMA901 Phase III trial in renal cell carcinoma

immatics initiates IMA901 Phase III trial in renal cell carcinoma

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

FDA's new sunscreen regulations will help reduce skin cancer risk

FDA's new sunscreen regulations will help reduce skin cancer risk

Calcium-sensing receptor plays key role in lethal lung cancer complication

Calcium-sensing receptor plays key role in lethal lung cancer complication

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.